The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II trial of neoadjuvant mFOLFOX 6 with panitumumab (P) in T3 rectal cancer with clear mesorectal fascia (MRF) and KRAS, NRAS, BRAF, PI3KCA wild type (4WT). GEMCAD 1601 PIER trial.
 
Carlos Fernandez-Martos
Consulting or Advisory Role - SERVIER
Research Funding - Amgen; Sanofi
Travel, Accommodations, Expenses - Amgen; Roche
Other Relationship - Amgen; Celgene; Sanofi; servier
 
Carles Pericay
No Relationships to Disclose
 
Joan Maurel
Consulting or Advisory Role - Amgen; Bayer; Biocartis; Incyte; Merck; NanoString Technologies; Roche
Research Funding - Catalan agency for management of University and research grants
 
Ana Virgili
Consulting or Advisory Role - Amgen; Roche
Speakers' Bureau - Amgen; Sanofi; SERVIER
Travel, Accommodations, Expenses - Amgen; Merck; MSD; Roche; Sanofi; SERVIER
 
Jaume Capdevila
Consulting or Advisory Role - Advanced Accelerator Applications; Bayer; Eisai; Exelixis; Ipsen; Lilly; Merck Serono; Novartis; Pfizer; Sanofi
Speakers' Bureau - Bayer; Eisai; Ipsen; Lilly; Merck Serono; Novartis; Pfizer; Sanofi
Research Funding - Advanced Accelerator Applications (Inst); AstraZeneca (Inst); Bayer (Inst); Eisai (Inst); Ipsen (Inst); Ipsen (Inst); Novartis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Eisai; Ipsen; Pfizer
 
Javier Gallego
Consulting or Advisory Role - Amgen; Bayer; Bristol-Myers Squibb; Celgene; Lilly; Roche
Speakers' Bureau - Amgen; Ipsen; Lilly; Novartis
Research Funding - Bristol-Myers Squibb (Inst); Lilly (Inst)
Expert Testimony - Lilly
Travel, Accommodations, Expenses - Amgen; Novartis
Other Relationship - Amgen; Amgen; Bristol-Myers Squibb; Merck
 
Ruth Vera
Consulting or Advisory Role - Amgen; Lilly; Merck; MSD; Roche; Sanofi; SERVIER
Speakers' Bureau - Amgen; Lilly; Merck; MSE; Roche; Sanofi; SERVIER
Travel, Accommodations, Expenses - Amgen; Lilly; Merck; MSD; Roche; Sanofi; SERVIER
 
Nuria Rodriguez-Salas
No Relationships to Disclose
 
Ferran Losa
No Relationships to Disclose
 
Manuel Valladares
Honoraria - Amgen; Bayer; Merck; Roche; Sanofi; SERVIER
Consulting or Advisory Role - Amgen; Merck; Sanofi; SERVIER
Research Funding - Amgen; Roche
 
Ana Vivancos
Consulting or Advisory Role - Bristol-Myers Squibb (Inst); Guardant Health (Inst); Incyte (Inst); Merck (Inst); Roche (Inst); Sysmex (Inst)
Research Funding - Bristol Meyers Squibb (Inst)
Patents, Royalties, Other Intellectual Property - FERRER (Inst)
 
Juan Ayuso
No Relationships to Disclose
 
Monique Maas
No Relationships to Disclose
 
Fernando Martínez
No Relationships to Disclose
 
Marcos Melian
Honoraria - Amgen; Merck; SERVIER
Consulting or Advisory Role - Merck; SERVIER
Speakers' Bureau - Amgen; Merck; SERVIER
Travel, Accommodations, Expenses - Amgen; SERVIER
 
Xabier García de Albéniz
No Relationships to Disclose